This site is intended for healthcare professionals only
LoginRegister
Jazz Pharmas Ziihera Gets USFDA Nod To Treat HER2-Positive Biliary Tract CancerJazz Pharma's Ziihera Gets USFDA Nod To Treat HER2-Positive Biliary Tract Cancer
Cipla Bommasandra facility gets VAI classification from USFDASetback to Cipla: DoP rejects plea challenging NPPA order for Acivir Tablets pricing
PfizerPfizer's HYMPAVZI gets European Commission Approval to Treat Severe Hemophilia A and B
Strides Pharma Secures NCLT Approval for OneSource, India’s First Specialty Pharma CDMOStrides Pharma Secures NCLT Approval for OneSource, India's First Specialty Pharma CDMO
Sun Pharma, Alembic and 1 other recall productsCipla Recalls Lanthanum Carbonate Tablets in US
Fire Destroys Primary Health Centre in NidmanoorHyderabad Pharma Plant Explosion Leaves 1 Dead, 3 Injured
One Death a Day: 1,705 Lives Lost in Indias Clinical Trials Since 2021, RTI RevealsSage Therapeutics' Experimental Drug for Huntington's Disease Fails Mid-Stage Trial
NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP UniformityNPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details
Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made MandatoryLupin's generic drug to treat ADHD symptoms gets USFDA approval
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMerck's Injectable Keytruda Proves Effective in Trial, Promises Easier Cancer Treatment
Unichem Labs Roha facility gets 3 USFDA observationsUSFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility
Novo Nordisk Launches Wegovy in South Africa, Ramping Up Obesity Drug Battle with Eli LillyNovo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients
X